Slides on Key Decisions in HIV Care: Rapid Initiation of ART

Learn key considerations for rapid initiation of ART. Topics include current recommendations and a discussion of the data to support ART options for rapid initiation.
Jason Halperin, MD, MPH
Jürgen K. Rockstroh, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.31 MB
Released: September 29, 2021

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Commentary from Dr Jason Halperin on the use of 2-drug ART for rapid start, from Clinical Care Options (CCO)

Jason Halperin, MD, MPH Released: November 29, 2021

Expert recap of new data on HIV drug resistance from EACS 2021, from Dr Babafemi Taiwo and Clinical Care Options (CCO)

Babafemi Taiwo, MBBS Released: November 23, 2021

Clinical Care Options (CCO) expert analysis of new data from EACS 2021, provided by expert HIV faculty

person default Tristan J. Barber, MA, MD, FRCP Released: November 22, 2021

Perspective on the contribution of mental health to the cascade of care in Europe, from Clinical Care Options (CCO) and Dr. Tristan Barber

person default Tristan J. Barber, MA, MD, FRCP Released: November 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue